EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties

被引:125
|
作者
Miao, H. [1 ,2 ]
Gale, N. W. [3 ]
Guo, H. [1 ,2 ]
Qian, J. [1 ,2 ]
Petty, A. [1 ,2 ]
Kaspar, J. [1 ,2 ]
Murphy, A. J. [3 ]
Valenzuela, D. M. [3 ]
Yancopoulos, G. [3 ]
Hambardzumyan, D. [4 ,5 ]
Lathia, J. D. [4 ,5 ]
Rich, J. N. [4 ,5 ]
Lee, J. [4 ,5 ]
Wang, B. [1 ,2 ,5 ]
机构
[1] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Rammelkamp Ctr Res, Cleveland, OH 44109 USA
[2] Case Western Reserve Univ, Sch Med, Dept Pharmacol & Oncol, Cleveland, OH 44109 USA
[3] Regeneron Pharmaceut Inc, VelociGene Div, Tarrytown, NY 10591 USA
[4] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44106 USA
[5] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44109 USA
关键词
EphA2; Akt; stem cells; glioma; invasion; ephrin-A; INTEGRATED GENOMIC ANALYSIS; HUMAN BRAIN; GLIOBLASTOMA; RECEPTOR; ACTIVATION; EXPRESSION; EPHRINA1; TUMORS; LIGAND; ROLES;
D O I
10.1038/onc.2013.590
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diffuse infiltrative invasion is a major cause for the dismal prognosis of glioblastoma multiforme (GBM), but the underlying mechanisms remain incompletely understood. Using human glioma stem cells (GSCs) that recapitulate the invasive propensity of primary GBM, we find that EphA2 critically regulates GBM invasion in vivo. EphA2 was expressed in all seven GSC lines examined, and overexpression of EphA2 enhanced intracranial invasion. The effects required Akt-mediated phosphorylation of EphA2 on serine 897. In vitro the Akt-EphA2 signaling axis is maintained in the absence of ephrin-A ligands and is disrupted upon ligand stimulation. To test whether ephrin-As in tumor microenvironment can regulate GSC invasion, the newly established Efna1;Efna3;Efna4 triple knockout mice (TKO) were used in an ex vivo brain slice invasion assay. We observed significantly increased GSC invasion through the brain slices of TKO mice relative to wild-type (WT) littermates. Mechanistically EphA2 knockdown suppressed stem cell properties of GSCs, causing diminished self-renewal, reduced stem marker expression and decreased tumorigenicity. In a subset of GSCs, the reduced stem cell properties were associated with lower Sox2 expression. Overexpression of EphA2 promoted stem cell properties in a kinase-independent manner and increased Sox2 expression. Disruption of Akt-EphA2 cross-talk attenuated stem cell marker expression and neurosphere formation while having minimal effects on tumorigenesis. Taken together, the results show that EphA2 endows invasiveness of GSCs in vivo in cooperation with Akt and regulates glioma stem cell properties.
引用
收藏
页码:558 / 567
页数:10
相关论文
共 50 条
  • [31] Functional Cross-Talk Between the Cellular Prion Protein and the Neural Cell Adhesion Molecule is Critical for Neuronal Differentiation of Neural Stem/Precursor Cells
    Prodromidou, Kanella
    Papastefanaki, Florentia
    Sklaviadis, Theodoros
    Matsas, Rebecca
    STEM CELLS, 2014, 32 (06) : 1674 - 1687
  • [32] Stanniocalcin 2 Promotes Neuronal Differentiation in Neural Stem/Progenitor Cells of the Mouse Subventricular Zone Through Activation of AKT Pathway
    Guo, Zhenyu
    Zhang, Hanyue
    Jingele, Xinbate
    Yan, Jing
    Wang, Xinxiang
    Liu, Yingxi
    Huang, Tingqin
    Liu, Chongxiao
    STEM CELLS AND DEVELOPMENT, 2024, 33 (19-20) : 551 - 561
  • [33] lncRNA TUG1 inhibits the cancer stem cell-like properties of temozolomide-resistant glioma cells by interacting with EZH2
    Cao, Yiqiang
    Chai, Wenying
    Wang, Yonggang
    Tang, Dang
    Shao, Dongchuan
    Song, Hai
    Long, Jiang
    MOLECULAR MEDICINE REPORTS, 2021, 24 (01)
  • [34] EPHA5 mediates trastuzumab resistance in HER2-positive breast cancers through regulating cancer stem cell-like properties
    Li, Yongfei
    Chu, Jiahui
    Feng, Wanting
    Yang, Mengzhu
    Zhang, Yanhong
    Zhang, Yanqiu
    Qin, Ye
    Xu, Juan
    Li, Jun
    Vasilatos, Shauna N.
    Fu, Ziyi
    Huang, Yi
    Yin, Yongmei
    FASEB JOURNAL, 2019, 33 (04) : 4851 - 4865
  • [35] The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells
    Brodie, Shlomit
    Lee, Hae Kyung
    Jiang, Wei
    Cazacu, Simona
    Xiang, Cunli
    Poisson, Laila M.
    Datta, Indrani
    Kalkanis, Steve
    Ginsberg, Doron
    Brodie, Chaya
    ONCOTARGET, 2017, 8 (19) : 31798 - 31814
  • [36] CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-κB-miR-21 pathways
    Ni, Su-Jie
    Zhao, Li-Qin
    Wang, Xiao-Feng
    Wu, Zhen-Hua
    Hua, Rui-Xi
    Wan, Chun-Hua
    Zhang, Jie-Yun
    Zhang, Xiao-Wei
    Huang, Ming-Zhu
    Gan, Lu
    Sun, Hua-Lin
    Dimri, Goberdhan P.
    Guo, Wei-Jian
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [37] Linc00668 Promotes Invasion and Stem Cell-Like Properties of Breast Cancer Cells by Interaction With SND1
    Qian, Wenchang
    Zhu, Yong
    Wu, Mingming
    Guo, Qianying
    Wu, Zhengsheng
    Lobie, Peter E.
    Zhu, Tao
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [38] COX-2 Promotes Migration and Invasion by the Side Population of Cancer Stem Cell-Like Hepatocellular Carcinoma Cells
    Guo, Zhe
    Jiang, Jing-Hang
    Zhang, Jun
    Yang, Hao-Jie
    Yang, Fu-Quan
    Qi, Ya-Peng
    Zhong, Yan-Ping
    Su, Jie
    Yang, Ri-Rong
    Li, Le-Qun
    Xiang, Bang-De
    MEDICINE, 2015, 94 (44) : e1806
  • [39] Sulfhydryl Angiotensin-Converting Enzyme Inhibitor Promotes Endothelial Cell Survival through Nitric-Oxide Synthase, Fibroblast Growth Factor-2, and Telomerase Cross-Talk
    Donnini, Sandra
    Terzuoli, Erika
    Ziche, Marina
    Morbidelli, Lucia
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 332 (03) : 776 - 784
  • [40] HIF1α/HIF2α induces glioma cell dedifferentiation into cancer stem cells through Sox2 under hypoxic conditions
    Wang, Pan
    Gong, Sheng
    Liao, Bin
    Pan, Jinyu
    Wang, Junwei
    Zou, Dewei
    Zhao, Lu
    Xiong, Shuanglong
    Deng, Yangmin
    Yan, Qian
    Wu, Nan
    JOURNAL OF CANCER, 2022, 13 (01): : 1 - 14